Jonkers, J.M.M.
Introduction
Cancer arises via a multistep process in which a normal cell progresses to a fully malignant tumor via a recurrent mechanism of clonal expansions triggered by (epi)genetic lesions (Vogelstein and Kinzler, 1993) . Such progression steps may involve reduced growth control, acquired invasiveness (Habets el al., 1994) or increased metastatic potential (MacDonald and Steeg, 1993) . Slow-transforming retroviruses, lacking viral oncogenes, are capable of activating cellular proto-oncogenes by insertional mutagenesis, and these agents have been shown to contribute directly to different stages of tumorigenesis (Jonkers and Berns, 1996) . Retrovirus-induced neoplasms acquire increasing numbers of proviruses in their genome during progression in vivo or passaging in vitro and, in various systems, more than one provirally activated proto-oncogene was found within a single cell (Tsichlis et ai., 1985; Cuypers et al, 1986; Peters et al, 1986) . Since the probability of simultaneous integration near two or more proto-oncogenes is negligible, consecutive integrations have to be assumed. Indeed, in Friend murine leukemia virus-induced erythroleukemias, proviral integrations in p53 appear to be preceded by retroviral activation of Flil (Howard et al, 1993) .
The multistep nature of Moloney murine leukemia virus (M-MuLV)-induced lymphomagenesis has been studied initially by monitoring clonal selections that occur after transplantation of primary tumors to syngeneic hosts. Proviral activation of Myc and Piml was frequently found in the same cell clone, suggesting cooperation between these genes in tumorigenesis (Cuypers et al, 1986) . In addition, prolonging the life span of M-MuLV-induced tumors by serial transplantations often results in the outgrowth of subclones carrying additional proviral integrations. Such integrations might mark genes that are associated with the growth advantage of these subclones. Molecular cloning of such an additional proviral integration site has led to the identification of the common insertion site Ticl (previously named Pim2) (Breuer et al, 1989) . Thus far, no gene has been identified that was affected by integrations in Ticl (J. Jonkers and M.Breuer, unpublished data) More recently, oncogene-bearing transgenic mice have been exploited in the experimental analysis of multistep tumorigenesis (Adams and Cory, 1992; Cardiff and Muller, 1993) . Retroviral infection of such mice was shown to be a particularly powerful strategy to identify genes that effectively collaborate with the transgene in tumorigenesis. Infection of E\l-Piml transgenic mice with M-MuLV revealed Myc or Nmycl rearrangements in almost 100% of the resulting T-cell lymphomas (van Lohuizen et al, 1989) and, in M-MuLV-induced B-cell lymphomas in E p.-myc transgenic mice, frequent proviral integrations were observed near Piml, BmillBlal and Pall (Haupt et al, 1991; van Lohuizen et al, 1991) . Employing oncogenebearing transgenic mice instead of normal mice may have additional advantages. Proviral tagging in transgenic animals allows focusing on a specific cell lineage and/or ) Oxford University Press 43 stage of differentiation, as these mice are predisposed to specific tumors by virtue of the nature and expression pattern of the trans-oncogene. Furthermore, this approach may facilitate the identification of additional hits, since the transgene constitutes the 'initiating' mutation in the transforming process. It is conceivable that these additional hits may affect not only oncogenes that cooperate with the transgene, but also genes that are more specifically involved in tumor progression.
Combining provirus tagging in oncogene-bearing transgenic mice with transplantation of primary lymphomas provides an opportunity to uncover genes primarily contributing to tumor progression. Here we describe such an approach with E\l-Piml or H2-K-myc transgenic mice, and report on the identification of a novel gene, designated Fratl (for frequently rearranged in advanced T-cell lymphomas), that is involved in progression of M-MuLVinduced T-cell lymphomas from these mice.
Results

Transplantation of MuLV-induced Eft-Pirn 7 T-cell lymphomas as a tool to monitor tumor progression
Infection of E\i-Piml transgenic mice with M-MuLV results in an accelerated onset of T-cell lymphomas which invariably harbor proviral insertions in Myc or Nmycl (van Lohuizen et al, 1989) . To generate primary and transplanted virus-induced E\l-Piml lymphomas, newborn offspring from crossings between heterozygous E\x-Piml mice and normal mice were infected with 10 4 -10 5 plaqueforming units (p.f.u.) of M-MuLV. Mice were sacrificed when moribund, and single-cell suspensions from tumor tissue (mesenteric lymph node) containing 10 7 viable cells were injected intravenously (i.V.) or intraperitoneally (i.p.) into three recipients each. Nearly all tumors (93%) were of T-cell origin, as was apparent from the rearrangements of the T-cell receptor (TCR) ß chain gene (data not shown). The proviral integration patterns of the resulting sets of primary and transplanted tumors were determined by Southern blot analysis. In several tumor sets, all transplanted tumors were derived from the predominant primary tumor cell clone, as judged by the essentially identical integration patterns. In some of these tumor sets, the transplanted tumors invariably had acquired an additional proviral insertion, illustrating that: (i) in the primary tumor, a novel subclone had emerged from the predominant tumor cell clone upon integration of a provirus; and (ii) the subclone with the extra provirus had expanded selectively after transplantation (Figure 1) . Hence, the additional proviral insertions might mark genes that are directly involved in the selective outgrowth of the affected cell clone. To investigate this possibility, three tumor sets of which the transplanted tumors had acquired one or two extra proviruses in loci distinct from Ticl were selected for molecular cloning of host DNA flanking the newly acquired proviral insertion.
Identification of a new common insertion site in transplanted Eß-piml T-cell tumors
Southern blot analysis of ÊcoRI-cleaved DNA from tumor set 35 with a probe specific for the U3 long terminal repeat (LTR) of M-MuLV revealed two fragments of 9.6 and 4.7 kb that were present in all transplanted tumors but not in the primary tumor. Both restriction fragments were cloned from size-selected libraries of EcoRI-digested tumor DNA. Restriction enzyme analysis showed that the 9.6 and 4.7 kb fragments represented the 5 ' and 3' provirus-host junctions of an integrated MCF provirus. A single copy probe from flanking cellular sequences (probe P6 in Figure 2B ) detected proviral insertions in the transplanted tumors from 10 out of 70 E \i.-Piml tumor sets. In three of these tumor sets, subclonal integrations could also be detected in the primary tumor, indicating that initial selection for integration in this locus had occurred in the primary tumor, prior to transplantation. The P6 probe was subsequently used to isolate a 37 kb genomic clone from a cosmid library, and a physical map of the locus, which we named Fratl, was constructed ( Figure 2A ). An interspecific mouse backcross mapping panel generated from crosses of C57BL/6J and Mus spretus mice (Copeland et al, 1993) To measure clonal expansion upon transplantation, these frequencies were corrected for clonality of the proviral insertions by estimating the relative hybridization intensity of DNA fragments corresponding to the rearranged allele and the germline allele. The resulting frequencies of proviral insertion are depicted in Figure 3A . While for the proviral occupancy of Myc, Nmycl and Pall no differences were observed between the primary and trans- planted EyL-Piml tumors, increased frequencies of proviral insertions near Ticl and Fratl were found in the transplanted tumors, compared with the primary tumors. Since initial selection for integrations near Ticl or Fratl occurs in the primary tumor, the observed increase reflects a clonal expansion of the fraction of tumor cells carrying a rearranged 77c/ or Fratl allele upon transplantation. We also screened for proviral activation of Tiaml, a gene which confers invasiveness to a lymphoma cell line in vitro (Habets et al., 1994) . Although proviral insertions in Tiaml were found rather frequently (15 out of 31 primary tumors; 23 out of 75 transplanted tumors), these integrations do not confer a strong selective advantage to the lymphoma cells in the protocol used ( Figure 3A) . Moreover, a number of primary tumors that harbored a provirus in Tiaml in a nearly clonal fashion resulted in transplanted tumors with no detectable proviral insertions in Tiaml.
Since PimllPim2 and MyclNmycl are strong collaborators in M-MuLV-induced T-cell lyrnphomagenesis (van Lohuizen et al, 1989; van der Lugt et al, 1995) , we determined whether proviral activation of FratI might also contribute to later stages of tumorigenesis in H2-Kmyc transgenic animals. These mice overexpress the myc gene predominantly in hematopoietic organs. H2-K-myc transgenic mice develop primarily T-cell lymphomas, in contrast to Eu.-myc transgenic animals, which are predisposed to B-cell tumors. Newborn offspring from crosses between heterozygous H2-K-myc transgenic mice and normal FVB mice were infected with 10 4 -10 5 infectious units of supF-M-MuLV (Reik etat, 1985) .SupF-MMuLV infection reduced the latency period of lymphoma induction from an average of 105 days to an average of 65 days. Flow cytometric analysis of 95 primary M-MuLVinduced lymphomas revealed that 93 tumors were of T-cell origin (67 TCRaß + CD4 + CD8", 8 TCRocß + CD4 + CD8 + , 5 TCR-yô + CD4 + CD8-and 13 oligoclonal T-cell lymphomas of mixed phenotype). Transplantation of primary lymphomas was performed by subcutaneous (s.c.) injection of 5 X 10 5 viable tumor cells into three syngeneic FVB/N recipients. Southern blot analysis of 23 primary and 46 transplanted H2-K-m>'c T-cell lymphomas with probes for Piml, Pall and F rati showed that also in these tumors proviral activation of Frail is a relatively late event in tumorigenesis, and that cell clones carrying integrations near Fratl expanded rapidly upon transplantation ( Figure 3B ).
Several tumor sets of monoclonal origin had sequentially acquired a provirus in two common insertion sites, thereby revealing both the order and the identity of three collaborating oncogenic events in a single cell clone, e.g. the transgene and two cellular proto-oncogenes. In a subset of E\l-Piml tumor sets with clonal integrations in either Myc or Nmycl, integrations near Fratl were detected in the transplanted tumors, suggesting that activation of Fratl can confer an additional selective advantage to lymphoma cells that overexpress Piml and Myc. Likewise, consecutive activation of Piml and Fratl, respectively, was observed in H2-K-myc tumor sets. In other H2-K-myc tumor sets, sequential activation of Pall and Fratl suggested collaboration between Myc, Pall and Fratl. While no significant variation in the frequency of Piml activation was observed between primary and transplanted H2-Kmyc lymphomas (8 out of 23 primary tumors; 18 out of 46 transplanted tumors), the frequencies that are calculated after correction for the clonality of the proviral insertions suggest that activation of Piml in these tumors may be preceded by other events ( Figure 3B ). The observation that integrations in Pall occasionally occur prior to activation of Piml is in agreement with this notion.
Proviral insertion at Fratl causes enhanced expression of the Fratl gene
As shown in Figure 2A , all proviruses in Fratl had integrated in the same transcriptional orientation in a small genomic region of -0.5 kb. In order to identify the gene affected by the proviral insertions at Fratl, Northern blots containing RNA from two E \l-Piml tumor sets with clonal insertions in Fratl (set 35 and 36) were hybridized with genomic probes derived from the Fratl locus ( Figure 2B ). All three probes used in this experiment recognized a 2.5 kb transcript in all tumors, including the primary tumors without a Fratl rearrangement. In addition to the normal 2.5 kb messenger, the transplanted tumors with a proviral insertion in Fratl showed high levels of truncated transcripts of 1.7 (tumor set 35) or 2.2 kb (tumor set 36). The truncated transcripts in the transplanted tumors could only be detected with probes located upstream of the proviral integration site, indicating that these niRNAs contain the 5 ' end of the parental 2.5 kb messenger and were terminated prematurely by the polyadenylation signal in the 5' LTR of the inserted provirus. Also, larger transcripts of 10-11 kb were found. They probably represent readthrough RNAs that have terminated in the 3 ' proviral LTR. In normal mouse tissues, low levels of Fratl mRNA were detected in spleen, thymus and brain (Figure 4 ). High expression was observed in testis where, in addition to the normal Frail transcript, a mRNA of 1.7 kb is very prominent. Fratl is also expressed at low levels during embryonic development.
Structure and sequence of Fratl
An oligo(dT)-primed cDNA library was constructed using poly(A)-selected RNA from tumor 35.1, which carries a proviral insertion in Fratl. Screening with probe 0.45Pst yielded two cDNA clones of 0.9 and 1.0 kb, respectively. Restriction enzyme analysis showed that these clones consist of Frail sequences fused to the 5' LTR. In both cDNA clones the 5 ' LTR sequence terminates at the U3 polyadenylation site, demonstrating that the presence of a provirus in the Fratl locus causes premature polyadenylation of Fratl transcripts. Both cDNA clones were sequenced, and a gene-specific primer (GSPI) was used to construct a GSP-primed tumor cDNA library that yielded two Fratl cDNA clones of 0.4 and 0.7 kb, respectively. The 5 ' end, as present in the longest cDNA clone, was confirmed by a 5' RACE protocol (Frohman el al., 1988) and by RNase protection (data not shown). The 3' Frail cDNA sequences were cloned by PCR amplification on cDNA from tumor 36.1, and by screening an oligo(dT)-primed murine thymus cDNA library with probe P5b. This screen yielded two cDNA clones of 0.9 and 1.2 kb, respectively, which both start at a poly(A) tail.
The nucleotide sequence of the Fratl cDNA reveals a long 3' untranslated region (UTR) (1469 nucleotides), an 822 nucleotide long open reading frame (ORF) and a short 5' UTR of 50 nucleotides ( Figure 5A ). The 3 ' UTR contains multiple copies of the ATTT motif thought to contribute to mRNA instability (Shaw and Kamen, 1986) . All insertions in Fratl cluster in a 500 bp region of DNA directly downstream of the protein-encoding domain, resulting in the production of 3'-truncated transcripts that encode an unaltered Fratl protein, while lacking a varying number of the mRNA-destabilizing motifs. The Fratl cDNA sequence proved to be completely co-linear with the genomic Fratl sequence, demonstrating that Fratl is an intronless gene. This feature allowed us to determine the human FRATI ORF via sequence analysis of a genomic clone. Comparison of the mouse Fratl and human FRATI amino acid sequences revealed that the ORF is conserved between man and mouse, with an amino acid identity of 78.5% and a similarity of 87.6% ( Figure 5B) . Likewise, hybridization of zoo blots with probe 0.45 Pst indicated that Fratl is well conserved among vertebrates (not shown).
The Fratl ORF encodes a polypeptide of 274 amino acid residues with a predicted M r of 29 kDa. The protein is largely hydrophilic, and an acidic domain is present in the N-terminal region (amino acids 6-22). Comparison of the mouse Fratl and human FRATI nucleotide and protein sequences with sequences present in the SwissProt or GenBank database did not show homologous proteins or common motifs. In vitro transcription and translation of Fratl proved to be very inefficient, even after addition of an N-terminal hemagglutinin tag with an AUG surrounded by an optimal Kozak sequence. Therefore, the integrity of the ORF was verified by transient expression of a GST-Frail fusion construct in COS cells ( Figure 5C ).
Infect/on of Eß-Pim1 tumor cells with a Fratl retrovirus results in a selective advantage in vivo
To test the effect of enhanced Fratl expression on the proliferation and metastatic potential of lymphoma cells in vivo, we constructed a retrovirus expressing both Fratl and ß-galactosidase via a bicistronic messenger. The use of a retroviral vector permitted an efficient introduction and overexpression of Frail in lymphoma cells. The presence of a ß-galactosidase reporter gene permitted monitoring of the infected tumor cells at the cellular level. Two T lymphoma cell lines, derived from spontaneous tumors in E ii-Piml transgenic FVB mice, were used in this experiment. In addition to the Piml transgene, Myc was found to be highly expressed in these cell lines, named DNPTHY and DNP13642 (data not shown). Upon s.c. injection into syngeneic recipients, these lymphoma lines gave rise exclusively to the formation of local tumors. This reproducible behavior allowed us to investigate whether overexpression of Fratl might induce the formation of metastases. FVB mice were injected s.c, either with mock-infected tumor cells or with a mixture of mock-infected cells and 1 or 2% transduced cells, and the resulting local tumors were analyzed as depicted in Figure 6 . Clonal expansion of the transduced fraction of tumor cells was observed in four out of six DNPTHY tumors and in six out of eight DNP 13642 tumors, demonstrating that overexpression of Fratl can confer an additional selective advantage in vivo to lymphoma cells that already overexpress Pirn 1 and Myc (Table I ). In addition to the local tumor, a number of other organs (liver, kidney, lung, heart, thymus, spleen or peripheral lymph nodes) were analyzed for the presence of tumor cells. No (micro)metastases were found in any of these tissues, indicating that differences could not be attributed to the injected tumor cells, since variations were also observed between mice that were injected with the same cell suspension. Apparently, the fate of the transduced tumor cells was also influenced by host factors. This notion was supported by experiments in which the same cell suspensions were injected i.p. or i.v. None of the resulting tumors contained an increased percentage of transduced lymphoma cells.
Discussion
To identify genes involved in progression of T-cell lymphomas, we have combined proviral tagging in oncogene-bearing E\i-Piml and H2-K-myc transgenic mice with transplantations of the primary tumors to syngeneic recipients as a means of allowing progression to higher malignancy. Molecular cloning of proviral insertion sites that were additionally and reproducibly found after transplantation of primary tumors has led to the identification of a novel locus, Fratl, that is frequently mutated by proviral insertions in the transplanted lymphomas from M-MuL.V-infectedEu.-P/HiV or H2-K-myc transgenic mice.
Integrations near Fratl constitute a relatively late event in T-cell lymphomagenesis. since several primary tumors of monoclonal origin were found to contain, in addition to the predominant cell clones lacking a provirus near Fratl, direct derivatives of these clones carrying proviral integrations near Fratl. Transplantation of such tumors resulted in a further expansion of the fraction of tumor cells with the rearranged Fratl allele, implying that activation of Fratl confers an additional selective advantage. Primary tumors of monoclonal origin, and the resulting transplanted tumors, have been instrumental in the identification of up to three collaborating oncogenes in T-cell lymphomagenesis: (i) the 'initiating' transgene; (ii) a common proviral insertion site that is clonal in both the primary tumor and the transplanted tumors; and (iii) a common proviral insertion site that is clonal in transplanted tumors but subclonal in primary tumors. In this way, a number of favorable combinations can be defined: Myc, Palt and Piml; Myc, Piml and FrarV; or Myc, Pall and Fratl. The fact that Fratl does not fall into any of the known complementation groups for lymphoid transformation ( MyclNmycl, PimllPinil and Pall/Bmil/Blal) suggests that Fratl acts in a distinct signal transduction pathway. Whether Fratl and the previously identified 'transplantation-specific' common insertion site 77cV belong to different complementation groups remains to be established. Mapping of the proviral insertion sites near the Fratl locus revealed that all proviruses had integrated in the same transcriptional orientation, in a small genomic region of -500 nucleotides. Using single copy probes from the genomic region upstream of the proviral insertions, we detected enhanced levels of truncated transcripts in all tumors carrying a proviral insertion near F rati. Sequence analysis of Fratl cDNA clones showed that the truncated transcripts terminate at the polyadenylation site present in the 5' LTR of the inserted provirus. Consequently, these transcripts lack most or all of the 3' -untranslated Fratl sequences, suggesting that both up-regulation of transcription by the viral enhancer and mRNA stabilization by the removal of negatively regulating elements in the 3 '-untranslated region may contribute to increased levels of Fratl mRNA. All proviral insertions leave the coding domain of Fratl intact, indicating that overexpression of normal Fratl protein contributes to transformation.
Apart from the N-terminal acidic region, the Fratl protein contains no apparent structural features that might provide us with clues about its function. The acidic regions of the yeast transcription factors GAL4 and GCN4 and the herpes simplex virus factor VP16 have been shown to be involved in transcriptional activation and proteinprotein interaction (Ma and Ptashne, 1987; Sigler, 1988) . and several proto-oncogenes, such as Evil (Perkins etal, 1991) , c-myb (Weston and Bishop, 1989) and Myc (Blackwell et al, 1990) , encode transcription factors containing an acidic region. It remains to be established whether Fratl has similar activities.
To examine the role of Fratl in tumor progression, we have developed a sensitive assay to monitor the selective advantage conferred by Fratl overexpression. DNPTHY and DNP 13642 lymphoma cells, which represent stable cell lines derived from spontaneous lymphomas in E (iPiml transgenic mice, were transduced with an MFGFratl-lRES-lacZ retrovirus followed by injection into syngeneic recipients, and outgrowth of the marked cell population was measured. This protocol allowed us to examine the effects of enhanced Fratl expression on cell proliferation and metastatic behavior in vivo. The data presented here demonstrate that overexpression of Fratl following retroviral transduction with MFG-Fra//-IRESlacZ can confer an additional selective advantage to lymphoma cells that already overexpress Piml and Myc. No selective outgrowth was observed when MFG-lacZ was used instead of MFG-Fratl-IRES-lacZ, confirming that the observed growth advantage of MFG-Frar/-1RES-/acZ-infected lymphoma cells can only be attributed to overexpression of Fratl. However, the selective outgrowth appears to be influenced by host factors, as significant variations were found when the same cell suspension was injected s.c. into different mice. Also, no selective outgrowth of the transduced subpopulation was observed after i.p. or i.v. inoculation. These results would be in accordance with a model in which activation of Fratl obviates the need for one or more specific growth factors that can contribute to the proliferation or survival of the lymphoma cells. In this case, the selective advantage of the Fra/7-overexpressing subpopulation would depend on the local concentration of these growth factors. Alternatively, the variations in selective outgrowth and the absence of detectable micrometastases might be caused by an immune response against the ß-galactosidase produced by the MFG-Fra//-lRES-/acZ-infected tumor cells. In line with the latter, it was reported recently that expression of the lacZ gene in the highly tumorigenic murine mastocytoma cell line P815 frequently caused a strong immune response in syngeneic recipients, resulting in the rejection of the tumor cells (Abina et al, 1996) . Since the MFGFra/'-IRES-/acZ-infected lymphoma cells produce a bicistronic messenger encoding both Fratl and LacZ, the selective growth advantage conferred by Fratl might be counteracted effectively by the selective removal of ß-galactosidase-expressing tumor cells by the immunocompetent host. While this potential complication might be circumvented by performing the transplantations in nude mice, the experiments described here strongly support the notion that Fratl can function as a tumor progression gene in lymphomagenesis.
In summary, we have used a tumor progression protocol based upon transplantation of M-MuLV-induced lymphomas from oncogene-bearing transgenic mice to identify a novel tumor progression gene, Frail. We have shown that this gene can confer an additional selective advantage in vivo to lymphoma cells that already overexpress Myc and Piml. While we do not yet understand the nature of this selective advantage, we expect that testing the effects of Fratl on the growth properties of a series of defined cell lines in vitro might provide clues about the function of this gene.
Materials and methods
Transgenic mice, lymphoma induction and transplantation of primary lymphomas The generation of E\i-Piml transgenic strains ppG66 and ppG64 has been described previously (van Lohuizen et ai, 1989) . Briefly, the transgene consists of a genomic Piml clone containing two copies of the immunoglobulin Eu. enhancer located upstream of the Piml promoter, and a single M-MuLV LTR within the 3' UTR. The transgene was introduced into (CBA/BrAXC57BL/LiA)Fl zygotes and the resulting mice were backcrossed with (CBA/BrAXC57BL/LiA)Fl, C57BL/UA or C57BL/6 mice.
The H2-K-/HVC construct was generated by fusing the H2-K promoter (Morello et al., 1986 ) lo a 5.5 kb Xbal-BamHl genomic mouse Myc fragment containing exons 2 and 3, including the Myc polyadenylation signal. The transgene was microinjecled into the pronuclei of FVB/N zygotes (Taketo et ai, 1991) . Genotyping was performed by Southern analysis of tail tip DNA according to Laird et al (1991) .
Lymphomas were induced by injecting l-day-old mice with 10 -10 infectious units of M-MuLV clone 1A as described (Jaenisch et al, 1975) . Mice were sacrificed when moribund, and tumor tissues (spleen, thymus, mesenteric/peripheral lymph nodes, liver) were frozen at -80°C. Transplantations and FACS analysis were performed with single-cell suspensions from mesenteric lymph node. Lymphomas from E\x~Piml transgenic animals were transplanted to (CBA/BrAXC57BL/LiA)Fl sex-matched recipients by i.v. or i.p. injection of I0 7 viable cells. Transplantation of lymphomas from H2-K-/n_yc transgenic animals was performed by s.c. injection of 5x10 s viable cells into syngeneic FVB/N females.
DNA and RNA analysis
High molecular weight DNA from lymphoma tissues was prepared as described (van der Putten et al, 1979) . For Southem analysis, 10 u.g of total genomic DNA of each tumor were digested with restriction enzymes as recommended by the supplier, separated on a 0.6% agarose gel, transferred to nitrocellulose and hybridized to 32 P-labeled probes. For Northern analysis, 20 Jig of total RNA, prepared by the LiCI-urea method, or 5 jJg of poly(A)-selected RNA were separated on 1% agarose formaldehyde gels (Sambrook et al., 1989) and transferred to nitrocellulose membranes. The following probes were used: Myc, 3 kb Xbal-Hindlll fragment (Shen-Ong et al, 1982) ; Nmycl, 3.5 kb Pstl fragment (Taya et al, 1986) ; Piml probe A, 0.9 kb BamHl fragment (Cuypers et al, 1984) ; Pall probe A, 1 kb Bglll-EcoRl fragment (van Lohuizen et al, 1991) ; Ticl probe MB20, 1.5 kb Pstl-EcoRl fragment (Breuer et al, 1989) ; Tiaml probe D22.3, 0.8 kb Sail fragment (Habets et al, 1994) ; M-MuLV U3 LTR, 180 bp Hpall fragment (Cuypers et al, 1984) ; and TCR ß chain probe 86T5 (Hedrick et al, 1984) . The Fratl probes used in this study were: QA5Pst, 0.45 kb Pstl fragment; P5a, 1.2 kb Xhol-Pstl fragment; P5b, 0.4 kb Pstl-Xhol fragment; and P6, 0.7 kb Bglll-EcoRl fragment.
Cloning
Cloning and subcloning of cDNAs and genomic DNAs were done according to established procedures (Sambrook et ai, 1989) . Clones were obtained from the following libraries: oligo(dT)-primed thymus cDNA (Stratagene), oiigo(dT)-primed testis cDNA (Clontech) and 129/ Sv genomic cosmid library (Stratagene).
For cDNA synthesis, 5 p.g of poly(A)-selected RNA from tumor 35.1 was used in a (dT)15-pnmed or GSP-primed (GSP1, 5'-CTCCTTGATG-AGGTTTCCC-3') cDNA reaction according to Gubler and Hoffman (1983) , with a cDNA synthesis kit from Boehringer Mannheim. cDNA was treated with T4 polymerase, size selected, and Notl linkers (Biolabs) were added. After digestion with Notl, cDNA was cloned in XZAPU. Libraries of 2-5 X 10 5 primary plaques were obtained. PCR amplification of RNA was performed by a first strand reverse transcriptase reaction (Boehringer Mannheim) with a gene-specific RT primer (GSP2, 5'-CGCTGCGTCCAGCTGCAGCGTCTCG-3') followed by 5' end cloning with the primers GSP3, 5'-CTGGACGATG-AGCTGGTC-3', and GSP4, 5'-CTCGAGCCACCCAGAGTCACC-3'. RACE conditions were essentially as described (Frohman et cil, 1988) . PCR amplification on cDNA from tumor 36.1 was performed with a M-MuLV-specific U3 LTR primer (AB949, 5'-CGCGTCGACCTTG-CCAAACCTACAGGT-3') and a Erat /-specific primer (GSP5, 5'-ACGACCTTCTTGTCCCTGGCAG-3').
Sequencing of Fratl cDNA and genomic clones was performed on both double-stranded templates and M13 single-stranded templates, using a Pharmacia T7 polymerase sequencing kit.
Construction of a Fratl retrovirus
The following restriction fragments were used in a three-point ligation reaction: (i) a 950 bp Ncol-Notl fragment, containing an in-frame fusion between an N-terminal hemagglutinin epitope tag and the Fratl coding sequences; (ii) a 1.7 kb Notl-Clal fragment from IRES-ßgeo (Pilipenko et ai, 1992) , containing an internal ribosomal entry site (1RES) and the N-terminal portion of Escherichia coli ß-galactosidase; and (iii) a 9 kb Ncol-Clal fragment containing the MFG retroviral vector (Dranoff et ai, 1993) and the C-terminal portion of ß-galactosidase. Introduction of the ensuing retroviral construct into producer cells (see below) resulted in the production of a bicistronic viral messenger encoding both Fratl and ß-galactosidase.
Tissue culture and transduction experiments Cell suspensions from spontaneous E\l-Piml lymphomas were seeded in tissue culture flasks containing subconfiuent BALB/c3T3 fibroblast feeder layers, at several dilutions. After a crisis, non-adherent tumor cells emerged and expanded rapidly. Lymphoma cells were grown in RPMI-1640 (Gibco-BRL) with 10% fetal calf serum (FCS; Gibco-BRL), 5X10" 5 M ß-mercaptoelhanol and antibiotics. \|/-CRE packaging cells (Danos and Mulligan, 1988) were cultivated in Dulbecco's modified Eagle's medium (Gibco-BRL) supplemented with 10% FCS and antibiotics. To generate y-CRE ecotropic virus-producing cell lines, \|/-CRE cells were co-transfected with MFG-Eratl-1 RES-la cZ and pRc/CMV (Invitrogen). After G4I8 selection, individual colonies were picked and analyzed for their transduction capacity.
Subconfluent producer cells (clone A1 ) were incubated with a minimal volume (10 ml/T75 flask) of medium. The supernatant was collected after 16 h and filtered through 0.45 u.m membrane filters. Infection was achieved by cultivating lymphoma cells for 2 h in freshly collected supernatant supplemented with polybrene (10 u.g/ml). The supernatant was replaced with RPMI-1640 medium and, 24 h after infection, the efficiency of transduction was determined by staining the cells for ß-galactosidase activity (Hogan et ai, 1994) . FVB mice were injected with mock-infected tumor cells or with a mixture of mock-infected cells and 2-3% transduced cells. S.c. injections were performed with 10 4 or 10 3 viable cells, i.p. injections with I0 4 viable cells and i.v. injections with 10 2 or I0 3 cells. Mice were sacrificed and analyzed when moribund, or when they had developed a local tumor. The resulting tumors were stained for ß-galactosidase activity as described elsewhere (Hogan et al, 1994) .
Flow cytometric analysis
A total of 10 6 cells were incubated in 96-well plates for 30 min at 4°C in 20 U. 1 PBA (phosphate-buffered saline with 1% bovine serum albumin and 0.1 % sodium azide) and saturating amounts of monoclonal antibody. Cells were washed twice with PBA and incubated with streptavidinphycoerythrin for biotinylated antibodies or PBA. The following antibodies were used: CD45R/B220 (clone 6B2), CD3 (clone 145-2CII), CD4 (clone RM4-5), CD8 (clone 53-6.7), TCRaß (clone H57-597) and TCRyô (clone GL3), all from PharMingen (San Diego, CA). Intracellular ß-galactosidase activity was measured using the fluorogenic substrate fluorescein-di-ß-D-galactopyranoside (FDG) in conjunction with flow cytometry (Berger et al, 1994) . In brief, 10 6 cells were incubated with a hypotonic solution containing 1 mM FDG for 50 s at 37°C. After addition of excess RPM1 medium to restore iso-osmotic conditions, the enzymatic reaction was allowed to proceed on ice for 2 h. All flow cytometric analyses were performed on a FACScan (Becton Dickinson).
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